V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Astrana Health Executive Compensation (FY25)

ASTH · Executive and director compensation, fiscal 2022 to 2025

The Astrana Health brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 7, 2026Latest filing (8-K): June 10, 2026
11 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Astrana Health brief$1,500Get the executive brief
176 figures on this page: 170 cited to the filing that reported them, 6 calculated from figures it prints. See the citations
Chief executive, fiscal 2025
◇
Brandon Sim
Latest say-on-pay support
=
June 10, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Brandon Sim: $10,362,866 → $14,930,231 (44.1% higher)
CEO pay ratio: 354:1 → 230:1 (35.0% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Astrana Health's chief executive and what were they paid?
Total compensation for Brandon Sim, Chief Executive Officer and President, came to $14,930,231 in fiscal 2025. Sim's total was 44.1% higher than the $10,362,866 reported for fiscal 2024.
What was Astrana Health's say-on-pay result?
The say-on-pay proposal drew 96.6% of votes cast for or against in favor at the meeting held June 10, 2026 for fiscal 2025.
Which companies are in Astrana Health's peer group?
The disclosed peer group includes agilon health, inc., Alignment Healthcare, Inc., Amedisys, Inc., BrightSpring Health Services, Inc. and Chemed Corporation, among others.
What is Astrana Health's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 230:1, against median employee compensation of $65,021.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Brandon Sim
Chief Executive Officer
◇◇◇———◇◇
Thomas Lam
President and Chief Medical Officer
◇—◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Brandon Sim
Chief Executive Officer
◇◇◇———◇◇
Thomas Lam
President and Chief Medical Officer
◇◇◇———◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Brandon Sim
Chief Executive Officer
◇—◇———◇◇
Thomas Lam
President and Chief Medical Officer
◇—◇———◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Brandon Sim
Chief Executive Officer and President
◇—◇—◇—◇◇
Dinesh Kumar
Chief Medical Officer
◇—◇—◇—◇◇
Chandan Basho
Chief Financial Officer and Chief Operating Officer
◇—◇—◇—◇◇
Kenneth Sim
Executive Chairman
◇◇————◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Brandon K. SimPSU◇◇◇—◇—◇
Brandon K. SimRSU◇——◇——◇
Chandan BashoRSU◇——◇——◇
Chandan BashoPSU◇◇◇—◇—◇
Dinesh KumarPSU◇◇◇—◇—◇
Dinesh KumarRSU◇——◇——◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Brandon SimRSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Chandan BashoPSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Kenneth SimRSU◇◇——
RSU◇◇——
RSU◇◇——
Dinesh KumarRSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Thomas S. Lam, M.D., M.P.H
—————◇◇
Mitchell W. Kitayama
Lead independent director
◇◇————◇
David G. Schmidt
◇◇————◇
John Chiang
◇◇————◇
Matthew Mazdyasni
◇◇————◇
Linda Dong
◇◇————◇
Weili Dai
◇◇————◇
J. Lorraine Estradas, R.N., B.S.N., M.P.H and Kenneth Sim, M.D served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as Restricted Stock.
Stock ownership guideline: 3x annual cash retainer ($240,000)

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • agilon health, inc. AGL
  • Alignment Healthcare, Inc. ALHC
  • Amedisys, Inc. AMED
  • BrightSpring Health Services, Inc. BTSG
  • Chemed Corporation CHE
  • Clover Health Investments, Corp. CLOV
  • Evolent Health, Inc. EVH
  • GoodRx Holdings, Inc. GDRX
  • Hims & Hers Health, Inc. HIMS
  • LifeStance Health Group, Inc. LFST
  • Option Care Health, Inc. OPCH
  • Oscar Health, Inc. OSCR
  • Privia Health Group, Inc. PRVA
  • Quest Diagnostics Incorporated DGX
  • RadNet, Inc. RDNT
  • Teladoc Health, Inc. TDOC

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 10, 2026=◇◇◇
2024June 11, 2025=◇◇◇
2023June 12, 2024=◇◇◇
2022June 13, 2023=◇◇◇
2021June 16, 2022=◇◇◇
2015September 14, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Astrana Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Astrana Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Astrana Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Astrana Health's disclosed peer group is defensible, who names Astrana Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
176 figures on this page: 170 cited to the filing that reported them, 6 calculated from figures it prints.
170 cited to the filing
6 calculated from the filing

Documents cited

  1. 0001104659-26-072343
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001104659-26-044536
    DIRECTOR COMPENSATION · EXECUTIVE COMPENSATION & · Grants of Plan-Based Awards · Grants of Plan-Based Awards in 2025 · and 2 more sections
  3. 000110465926044536
    CEO Pay Ratio
  4. 0001104659-25-058542
    Item 5.07 Submission of Matters to a Vote of Security Holders
  5. 0001104659-25-039438
    Summary Compensation Table · Summary Compensation Table (“SCT”)
  6. 0001104659-24-070847
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0001104659-24-050983
    Summary Compensation Table · Summary Compensation Table (“SCT”)
  8. 0001104659-23-072288
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001628280-23-014191
    Summary Compensation Table
  10. 0001628280-22-017771
  11. 0001144204-16-124177
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Astrana Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/ASTH (accessed 2026).
Short form: data: Velarion

The Astrana Health brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
11 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Astrana Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Astrana Health discloses

The companies named in ASTH's own disclosed peer group.

agilon health, inc.Alignment Healthcare, Inc.BrightSpring Health Services, Inc.Chemed CorporationClover Health Investments, Corp.Evolent Health, Inc.GoodRx Holdings, Inc.Hims & Hers Health, Inc.LifeStance Health Group, Inc.Option Care Health, Inc.Oscar Health, Inc.Privia Health Group, Inc.Quest Diagnostics IncorporatedRadNet, Inc.Teladoc Health, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy